HIGHLIGHTS
- who: Yayu Zou et al. from the College of Pharmacy, Guizhou University, Guiyang, China have published the Article: Discovery of Tryptanthrin and Its Derivatives and Its Activities against NSCLC In Vitro via Both Apoptosis and Autophagy Pathways, in the Journal: (JOURNAL)
- what: In this study a series of novel tryptanthrin derivatives were synthesized and their inhibitory activities against selected human cancer cell lines namely lung (A549) chronic myeloid leukemia (K562) prostate (PC3) and live (HepG2) were evaluated using a methyl thiazolyl tetrazolium colorimetric (MTT) assay. The results suggested that that the combination of autophagy tryptanthrin . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.